Iobenzamic acid | CAS#3115-05-7

MedKoo Cat#: 535099 | Name: Iobenzamic acid

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Iobenzamic acid is a bioactive chemical.

Chemical Structure

Iobenzamic acid

CAS#3115-05-7

Theoretical Analysis

MedKoo Cat#: 535099

Name: Iobenzamic acid

CAS#: 3115-05-7

Chemical Formula: C16H13I3N2O3

Exact Mass: 661.8060

Molecular Weight: 662.00

Elemental Analysis: C, 29.03; H, 1.98; I, 57.51; N, 4.23; O, 7.25

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

Iobenzamic acid

IUPAC/Chemical Name

beta-Alanine, N-(3-amino-2,4,6-triiodobenzoyl)-N-phenyl-

InChi Key

FJYJNLIEGUTPIJ-UHFFFAOYSA-N

InChi Code

InChI=1S/C16H13I3N2O3/c17-10-8-11(18)15(20)14(19)13(10)16(24)21(7-6-12(22)23)9-4-2-1-3-5-9/h1-5,8H,6-7,20H2,(H,22,23)

SMILES Code

O=C(O)CCN(C(C1=C(I)C=C(I)C(N)=C1I)=O)C2=CC=CC=C2

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 662.00 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Suzuki H, Kadena N, Takeuchi K, Nakagawa S. Effects of three-day oral cholecystography on serum iodothyronines and TSH concentrations: comparison of the effects among some cholecystographic agents and the effects of iopanoic acid on the pituitary-thyroid axis. Acta Endocrinol (Copenh). 1979 Nov;92(3):477-88. doi: 10.1530/acta.0.0920477. PMID: 517049. 2: MILITEANU Z. [CHOLECYSTOGRAPHY WITH OSBIL]. Harefuah. 1964 Sep 15;67:204-6. Swedish. PMID: 14199859. 3: WRIGHT FW. "OSBIL"--A CLINICAL TRIAL. Clin Radiol. 1965 Jul;16:302-3. doi: 10.1016/s0009-9260(65)80066-6. PMID: 14324895. 4: TSUNEMOTO H, YAMAGAMI T. [Gallbladder shadows with Osbil]. Rinsho Hoshasen. 1963 Mar;8:188-94. Japanese. PMID: 13994603. 5: SCHLAGER K, SCHUSTER H. [Osbil, a new oralbile contrast medium]. Wien Klin Wochenschr. 1962 Jan 12;74:28-9. German. PMID: 14498496. 6: EGEBLAD M. OSBIL: ET NYT KONTRASTSTOF TIL ORAL KOLECYSTOGRAFI [OSBIL: A NEW CONTRAST MEDIUM FOR ORAL CHOLECYSTOGRAPHY]. Nord Med. 1963 Aug 15;70:914-5. Swedish. PMID: 14045699. 7: SACK GM. [Osbil, a new contrast medium for oral cholangiocholecystography]. Med Klin. 1961 Jul 7;56:1178-9. German. PMID: 13745243. 8: VUORINEN P, HELELAE T. KOKEMUKSIA PERORAALISESTA OSBIL--SAPPIVARJO-AINEESTA [EXPERIENCE WITH OSBIL, A PERORAL CHOLEGRAPHIC MEDIUM]. Duodecim. 1964;80:151-3. Swedish. PMID: 14133972. 9: RAVELLI R. [Osbil, a new peroral gallbladder contrast medium]. Wien Klin Wochenschr. 1962 Feb 23;74:133-5. German. PMID: 14490633. 10: SCHIFINO A, VECCHIO C. UN NUOVO MEZZO DI CONTRASTO PER COLECISTOGRAFIA: L'OSBIL [A NEW CONTRAST MEDIUM FOR CHOLECYSTOGRAPHY: OSBIL]. Minerva Radiol Fisioter Radiobiol. 1964 Jul-Aug;16:329-33. Italian. PMID: 14187600. 11: GIMES B. [Experience with Osbil, a contrast medium for oral cholecystography]. Orv Hetil. 1962 Feb 11;103:268-9. Hungarian. PMID: 13898724. 12: FLEISCHMANN E, WANEK G. [Experience with Osbil, a new oral biliary contrast medium]. Wien Med Wochenschr. 1962 Feb 17;112:146-7. German. PMID: 13893507. 13: AFSCHARIAN M. ERFAHRUNGEN UEBER DIE DARSTELLUNG DER GALLENBLASE UND DES DUCTUS CHOLEDOCHUS MIT OSBIL AN EINEM KRANKENGUT VON 413 PATIENTEN [EXPERIENCES WITH VISUALIZING THE GALLBLADDER AND THE BILE DUCTS WITH OSBIL IN A PATIENT MATERIAL OF 413 CASES]. Med Welt. 1964 Aug 15;33:1741-4. German. PMID: 14247969. 14: BRAUN H, AMMON K. [Experiences with the biliary contrast medium Osbil in 280 cases]. Fortschr Geb Rontgenstr Nuklearmed. 1962 Jun;96:784-6. German. PMID: 13872588. 15: WEILNE LEICHNER Z, GYURU G. [The advantage of cholangiography and cholecystography performed with Osbil in demonstrating gallbladder adhesions]. Orv Hetil. 1962 Sep 16;103:1749-50. Hungarian. PMID: 13999571. 16: HELFFERICH KH. [Results and experiences with a new gallbladder contrast medium (Osbil) and a contrast medium in dry form]. Med Welt. 1962 Sep 22;38:2011-2. German. PMID: 13953562. 17: HEALEY T, GRAINGER RG. A CLINICAL TRIAL OF ORAL CHOLECYSTOGRAPHIC MEDIA: TELEPAQUE, BILOPTIN, OSBIL TABLETS AND OSBIL CAPSULES. Br J Radiol. 1965 Jan;38:57-62. doi: 10.1259/0007-1285-38-445-57. PMID: 14236022. 18: HEIDE M. ERFAHRUNGEN BEI DER ORALEN CHOLEZYSTO-CHOLANGIOGRAPHIE MIT OSBIL ALS GALLENBLASENKONTRASTMITTEL UND EIGELB-SORBIT-TAFELN (KM-TAFELN) ALS KONTRAKTIONSMITTEL [EXPERIENCES IN ORAL CHOLECYSTOCHOLANGIOGRAPHY WITH OSBIL AS GALLBLADDER CONTRAST MEDIUM AND EGG-YOLK-SORBITOL TABLETS (CM TABLETS0 AS CONTRACTION MEDIUM]. Med Klin. 1965 Jun 18;60:996-7. German. PMID: 14306881.